LUTRELEF subst sèche 3.2 mg c solv flac
7680473660388
CH-47366
H01CA01
07.03.1.
Reimbursement limitations:
LUTRELEF
Hypogonadisme hypothalamo-hypophysaire chez l'homme.
Activation de la fonction ovarienne chez la femme en cas de:
…
1 / 3
google
Details
- Product number
- 4736602
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio cryodesiccata: gonadorelini acetas 3.2 mg corresp. gonadorelinum 2.91 mg, mannitolum acidum hydrochloridum, pro vitro. Solvens: natrii chloridum corresp. natrium 35.4 mg, acidum hydrochloridum, aqua ad iniectabile 10 ml.
Articles (1)
Lutrelef 3,2 mg, Injektionspräparat
Injektionspräparat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
SOLV
|
- | Substance | HNIDK |
|
PRC
|
3.2 MG | Substance | WIZUS |
|
SOLV
|
35.4 MG | Substance | HBESI |
|
PRC
|
2.91 MG | Substance | Wirkstoff (Principe actif) |
|
SOLV
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
SOLV
|
10.0 ML | Substance | HNIDK |
Reimbursement information
Public price
CHF 343.45
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
15/03/1991
Authorization holder
Ferring AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 47366
- Drug name
- Lutrelef, Injektionspräparat
- Galenic form
- PULMJ
- ATC Code
- H01CA01
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 04/08/1986
- Authorization expiration date
- 31/12/9999
- IT number
- 07.03.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- LUTRELEF subst sèche 3.2 mg c solv flac
- Description (DE)
- LUTRELEF Trockensub 3.2 mg c Solv Durchstf
- Market launch
- 04/08/1986
- Narcotic (BTM)
- No